1Buy.AI | $3,900,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
DexMat | $5,000,000 | (Feb 3, 2026) Certified by Founder
Lodge
Avenue Therapeutics
start up
United States
- New York, NY
- 13/12/2021
- Unknown
- $2,000,000
Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) Company, is a specialty pharmaceutical company.
Please be aware of Recruiting Fraud: https://www.avenuetx.com/beware-of-recruiting-fraud/
- Industry Biotechnology Research
- Website https://www.avenuetx.com/
- LinkedIn https://www.linkedin.com/company/avenue-therapeutics/
Related People
Lucy LuFounder
United States -
New York City Metropolitan Area
I am an executive of a development-stage biotech company. Prior to working in the biotech industry, I was a senior equity analyst covering small- to mid-cap biotechnology companies. My expertise includes strategic planning, clinical development, regulatory strategy, business development, biotech equity valuation, investor relations and capital markets.
Prenosis | $20,000,000 | (Feb 3, 2026)
Poetiq | $45,800,000 | (Feb 3, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)